NCT00702416

Brief Summary

This study has been designed to assess the possible advantages of using ultrasound imaging to block the brachial plexus (i.e., nerves of the upper limb) in patients undergoing shoulder surgery. The ultrasound technique will be compared with the current gold standard, electrical nerve stimulation. The aim of this study is to define which technique is better in terms of time to onset of anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started May 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2008

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 19, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 20, 2008

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2009

Completed
Last Updated

November 16, 2009

Status Verified

November 1, 2009

Enrollment Period

1.5 years

First QC Date

June 19, 2008

Last Update Submit

November 13, 2009

Conditions

Keywords

Analgesia, Patient-controlledAnesthesia, RegionalUltrasoundPostoperative PainBrachial Plexus

Outcome Measures

Primary Outcomes (1)

  • Onset time of brachial plexus anesthesia

    ≤30 min

Secondary Outcomes (8)

  • Successful brachial plexus anesthesia

    ≤30 min

  • Additional analgesic requirements during surgery

    Duration of surgery

  • Incidence of paresthesiae during the anesthetic procedure

    ≤30 min

  • Incidence of blood aspiration during the anesthetic procedure

    ≤30 min

  • Number of needle redirections for the performance of the block

    ≤30 min

  • +3 more secondary outcomes

Study Arms (2)

US Group

EXPERIMENTAL

In this group, the continuous block will be performed under real-time ultrasound (US) guidance.

Procedure: Ultrasound-guided continuous interscalene brachial plexus blockDrug: RopivacaineDrug: ParacetamolDrug: MorphineDrug: FentanylProcedure: General anesthesia

ENS Group

ACTIVE COMPARATOR

In this group, the continuous block will be performed with an electrical nerve stimulation (ENS) technique.

Procedure: Continuous interscalene brachial plexus block using electrical nerve stimulationDrug: RopivacaineDrug: ParacetamolDrug: MorphineDrug: FentanylProcedure: General anesthesia

Interventions

With patients in the supine position, a high-frequency (10-12 MHz) ultrasound transducer in a sterile sheath will be applied to explore the interscalene region and locate the brachial plexus. The transducer will be positioned so as to image the C5 and C6 roots in a single view. Visualization of the C7 root in the same scan will be sought, but will not be required. A 50-mm, 20 G needle will be advanced in-plane from the postero-lateral side of the transducer. Injection of the local anesthetic will be performed in small aliquots while repositioning of the needle in order to optimize spread of the injectate around the nerve roots. At the end of the injection, a catheter will be threaded through the needle. The catheter will be positioned to lie deep and close to the imaged nerve roots.

Also known as: Peripheral nerve block, Ultrasound, Regional anesthesia
US Group

With patients in the supine position, the head will be rotated to the contralateral side. The interscalene groove will be palpated. A 35-mm, 20 G needle will be inserted at the estimated C6 level (cricoid cartilage) with a 30-45° angle to the skin. The needle will be advanced along a line joining the insertion site to the axilla. An electrical nerve stimulator will be used at an initial intensity of 1.0 mA (frequency: 2 Hz, pulse width: 0.2 ms). A musculocutaneous or axillary-nerve mediated twitch will be sought Injection of the local anesthetic will start with a visible motor response at a current \<0.5 mA. The catheter will be positioned to as to elicit a motor response at ≤0.4 mA.

Also known as: Peripheral nerve block, Electrical nerve stimulation, Regional anesthesia
ENS Group

Block induction \[1% (wt/vol) solution\]: 20 ml (200 mg) Postoperative analgesia \[0.2% (wt/vol) solution\]: * Background infusion: 4 ml/h (8 mg/h) * Incremental on-demand dose: 2 ml (4 mg) * Lockout time: 15 min

Also known as: Naropin, Local anesthetic, Amide local anesthetic
ENS GroupUS Group

1 g iv q8h

Also known as: Acetaminophen, Perfalgan, Analgesic
ENS GroupUS Group

5 mg im prn q1h (in the postoperative period)

Also known as: Opioid, Narcotic, Analgesic
ENS GroupUS Group

50 µg iv prn (in the intraoperative period)

Also known as: Opioid, Narcotic, Analgesic
ENS GroupUS Group

Will be given in case of block failure and/or patient discomfort intractable with fentanyl during the procedure. The technique will be left at the discretion of the attending anesthesiologist. Monitored anesthesia care will also be acceptable; the block will be considered as failed in that case as well.

Also known as: Monitored anesthesia care
ENS GroupUS Group

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA Physical Status Class I-III
  • Elective surgery of the shoulder
  • Informed consent to regional anesthesia

You may not qualify if:

  • Inability to effectively communicate
  • Chronic opioid use
  • Absence of informed consent to participation to the study
  • Ipsilateral upper limb neurological deficits
  • Known allergy to study medications
  • Contraindications to continuous block placement

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital / Azienda Ospedaliero-Universitaria

Parma, PR, 43100, Italy

Location

Related Publications (4)

  • Casati A, Fanelli G, Aldegheri G, Berti M, Colnaghi E, Cedrati V, Torri G. Interscalene brachial plexus anaesthesia with 0.5%, 0.75% or 1% ropivacaine: a double-blind comparison with 2% mepivacaine. Br J Anaesth. 1999 Dec;83(6):872-5. doi: 10.1093/bja/83.6.872.

    PMID: 10700785BACKGROUND
  • Stevens MF, Werdehausen R, Golla E, Braun S, Hermanns H, Ilg A, Willers R, Lipfert P. Does interscalene catheter placement with stimulating catheters improve postoperative pain or functional outcome after shoulder surgery? A prospective, randomized and double-blinded trial. Anesth Analg. 2007 Feb;104(2):442-7. doi: 10.1213/01.ane.0000253513.15336.25.

    PMID: 17242107BACKGROUND
  • Casati A, Borghi B, Fanelli G, Montone N, Rotini R, Fraschini G, Vinciguerra F, Torri G, Chelly J. Interscalene brachial plexus anesthesia and analgesia for open shoulder surgery: a randomized, double-blinded comparison between levobupivacaine and ropivacaine. Anesth Analg. 2003 Jan;96(1):253-9, table of contents. doi: 10.1097/00000539-200301000-00051.

    PMID: 12505962BACKGROUND
  • Casati A, Danelli G, Baciarello M, Corradi M, Leone S, Di Cianni S, Fanelli G. A prospective, randomized comparison between ultrasound and nerve stimulation guidance for multiple injection axillary brachial plexus block. Anesthesiology. 2007 May;106(5):992-6. doi: 10.1097/01.anes.0000265159.55179.e1.

    PMID: 17457131BACKGROUND

MeSH Terms

Conditions

AgnosiaPain, Postoperative

Interventions

High-Energy Shock WavesAnesthesia, ConductionTranscutaneous Electric Nerve StimulationRopivacaineAnesthetics, LocalAcetaminophenAnalgesicsMorphineAnalgesics, OpioidNarcoticsFentanylAnesthesia, General

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesPain

Intervention Hierarchy (Ancestors)

Ultrasonic WavesSoundRadiation, NonionizingRadiationPhysical PhenomenaAnesthesiaAnesthesia and AnalgesiaElectric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesAnestheticsCentral Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesSensory System AgentsPeripheral Nervous System AgentsCentral Nervous System AgentsTherapeutic UsesAcetanilidesMorphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic CompoundsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic CompoundsPiperidinesHeterocyclic Compounds, 1-Ring

Study Officials

  • Giorgio Danelli, MD

    UO II Anestesia, Rianimazione e Terapia Antalgica, AOU Parma

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 19, 2008

First Posted

June 20, 2008

Study Start

May 1, 2008

Primary Completion

November 1, 2009

Study Completion

November 1, 2009

Last Updated

November 16, 2009

Record last verified: 2009-11

Locations